Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Roquefort Thera Share Price
  4. Roquefort Thera Share Regulatory News

Pin to quick picksRoquefort Thera Regulatory News (ROQ)

Roquefort Thera Information
  • There is currently no data for ROQ
1234
Date   Source Headline
6th Feb 20247:00 amRNSOperations Update
24th Nov 20237:00 amRNSChange of Auditor
6th Nov 20237:00 amRNSSignificant Mesodermal Killer Cell Milestone
27th Sep 20237:00 amRNSInterim Results to 30 June 2023
22nd Sep 202311:42 amRNSInvestor Presentation via Investor Meet Company
14th Aug 20237:00 amRNSExpansion of Patent Portfolio
7th Aug 20237:00 amRNSDevelopment of New Novel siRNA Therapeutics
2nd Aug 20237:00 amRNSDirector/PDMR Shareholding
12th Jul 202310:27 amRNSDirector/PDMR Shareholding
29th Jun 202310:05 amRNSResults of AGM
29th Jun 20237:00 amRNSAGM Statement
27th Jun 20237:00 amRNSInvestor Presentation via Investor Meet Company
26th Jun 20232:41 pmRNSDirector/PDMR Shareholding
26th Jun 202310:36 amRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSDirector/PDMR Shareholding
22nd Jun 20237:00 amRNSRNA Medicine Shows In Vitro Anti-Cancer Efficacy
19th Jun 20237:00 amRNSAntibody Program Results & Orphan Drug Indication
13th Jun 20237:00 amRNSAnti-Cancer MDK mRNA - Positive in vitro Results
7th Jun 202310:11 amRNSRestoration of Trading
6th Jun 20237:00 amRNSNotice of Annual General Meeting
5th Jun 20237:00 amRNSAnnual Report & Financial Statements - 31 Dec 2022
2nd May 20237:56 amRNSSuspension of Trading Pending 2022 Annual Report
2nd May 20237:30 amRNSSuspension - Roquefort Therapeutics plc
13th Mar 20237:30 amRNSConfirmation of No Exposure to Silicon Valley Bank
8th Mar 20237:00 amRNSCreation of New Novel Family of mRNA Therapeutics
6th Mar 20237:00 amRNSFormation of Scientific Advisory Board
1st Mar 20237:00 amRNSCompany Presentation
21st Feb 20237:00 amRNSInvestor Presentation
20th Feb 20237:00 amRNSRandox Licence and Royalty Agreement
24th Jan 20237:00 amRNSMDK Oncology Antibodies Demonstrate In-Vivo Safety
18th Jan 20238:36 amRNSHolding(s) in Company
16th Jan 20237:00 amRNSAppointment of Auditor
9th Jan 20237:00 amRNSOperations Update
5th Dec 20228:07 amRNSPresentation of Midkine Oligonucleotide Program
1st Dec 20222:00 pmRNSResignation of Auditor
25th Oct 20227:00 amRNSMidkine Antibody Program - Festival of Biologics
11th Oct 20227:00 amRNSROQ Presents Study Results at the ESGCT Conference
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20222:30 pmRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSInterim Results to 30 June 2022
23rd Sep 20227:00 amRNSInterim Results to 30 June 2022
16th Sep 20228:00 amRNSInvestor Presentation
16th Sep 20227:01 amRNSBoard and Management Appointments
16th Sep 20227:00 amRNSAcquisition Completion, Admission & Voting Rights
15th Sep 202212:26 pmRNSNotice of Admission
13th Sep 202211:08 amRNSPublication of Prospectus
11th Aug 20227:00 amRNSPre-clinical Program & Transaction Update
20th Jul 20227:00 amRNSAppointment of Joint Broker
15th Jul 20227:00 amRNSCommencement of Trading on US OTCQB Venture Market
4th Jul 20224:57 pmRNSDirector/PDMR Shareholding
1234

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
JAR
Jardine Math.sr
LSE
0.00%
UTL
Util
LSE
-2.45%
CBU0
iShares USD Treasury Bond 7-10yr UCITS ETF (Acc)
LSE
-0.08%
EMDG
L&G Emerging Markets Government Bond (USD) 0-5 Year Screened UCITS ETF USD Dist
LSE
0.49%
FDM.GB.PL
Fdm Group Holdings Plc
AQSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-5.26%
PREM
Premier African Minerals
LSE
2.44%
ITM
Itm Power
LSE
-2.57%
MATD
Petro Matad
LSE
-4.00%
PRD
Predator Oil
LSE
-5.11%